Skip to content
University of Florida
Logo for UF Innovate
University of Florida
  • FOR ENTREPRENEURS
    • Accelerate
    • Events
    • Entrepreneurship & More
    • Search Technologies
  • FOR ENTREPRENEURS
    • Accelerate
    • Events
    • Entrepreneurship & More
    • Search Technologies
  • FOR INNOVATORS
    • Report a New Discovery
    • Innovator’s Guide
    • Read UF’s IP Policy
    • FAQ & Resources
  • FOR INNOVATORS
    • Report a New Discovery
    • Innovator’s Guide
    • Read UF’s IP Policy
    • FAQ & Resources
  • About
    • News
    • Events
    • Tech Tuesday
      • Tech Tuesday Interest Form
    • Success Stories
  • Tech Licensing
    • Innovators
      • Innovator Portal
      • Innovator’s Guide
      • FAQ & Resources
      • Request MTA
    • Startups
    • Industry
      • Search Technologies
    • Internships
  • Ventures
    • EIRs Advisory Board
    • Submit Your Pitch Deck
    • Got What It Takes To Be An EIR?
  • Accelerate
    • Apply
    • The Hub
    • Sid Martin Biotech
    • Sponsorship
    • Mentor Program
    • Programs
    • Collaboratory
  • Pathways
    • Get Started
    • Foundational Training
    • NSF I-Corps
    • Development & Translational Support
    • Entrepreneurship & More
      • SBIR and STTR Grant Funding
    • Mentorship, Collaboration & Outreach
  • UF Research
  • Contact Us
  • About
    • News
    • Events
    • Tech Tuesday
      • Tech Tuesday Interest Form
    • Success Stories
  • Tech Licensing
    • Innovators
      • Innovator Portal
      • Innovator’s Guide
      • FAQ & Resources
      • Request MTA
    • Startups
    • Industry
      • Search Technologies
    • Internships
  • Ventures
    • EIRs Advisory Board
    • Submit Your Pitch Deck
    • Got What It Takes To Be An EIR?
  • Accelerate
    • Apply
    • The Hub
    • Sid Martin Biotech
    • Sponsorship
    • Mentor Program
    • Programs
    • Collaboratory
  • Pathways
    • Get Started
    • Foundational Training
    • NSF I-Corps
    • Development & Translational Support
    • Entrepreneurship & More
      • SBIR and STTR Grant Funding
    • Mentorship, Collaboration & Outreach
  • UF Research
  • Contact Us
  • About
    • News
    • Events
    • Tech Tuesday
      • Tech Tuesday Interest Form
    • Success stories
  • Tech Licensing
    • Innovators
      • Innovator Portal
      • Innovator’s Guide
      • FAQ & Resources
      • Request MTA
    • Startups
    • Industry
      • Search Technologies
    • Internships
  • Ventures
    • EIRs Advisory Board
    • Submit Your Pitch Deck
    • Got What It Takes To Be An EIR
  • Accelerate
    • Apply
    • The Hub
    • Sid Martin Biotech
    • Sponsorship
    • Mentor Program
    • Programs
    • Collaboratory
  • Pathways
    • Get Started
    • Foundational Training
    • NSF I-Corps
    • Development & Translational Support
    • Entrepreneurship & More
      • SBIR and STTR Grant Funding
    • Mentorship, Collaboration & Outreach
  • UF Research
  • Contact Us
  • For Innovators
    • Report a New Discovery
    • Innovator’s Guide
    • Read UF’s IP Policy
    • FAQ & Resources
  • For Entrepreneurs
    • Search Technologies
    • Accelerate
    • Entrepreneurship & More
  • About
    • News
    • Events
    • Tech Tuesday
      • Tech Tuesday Interest Form
    • Success stories
  • Tech Licensing
    • Innovators
      • Innovator Portal
      • Innovator’s Guide
      • FAQ & Resources
      • Request MTA
    • Startups
    • Industry
      • Search Technologies
    • Internships
  • Ventures
    • EIRs Advisory Board
    • Submit Your Pitch Deck
    • Got What It Takes To Be An EIR
  • Accelerate
    • Apply
    • The Hub
    • Sid Martin Biotech
    • Sponsorship
    • Mentor Program
    • Programs
    • Collaboratory
  • Pathways
    • Get Started
    • Foundational Training
    • NSF I-Corps
    • Development & Translational Support
    • Entrepreneurship & More
      • SBIR and STTR Grant Funding
    • Mentorship, Collaboration & Outreach
  • UF Research
  • Contact Us
  • For Innovators
    • Report a New Discovery
    • Innovator’s Guide
    • Read UF’s IP Policy
    • FAQ & Resources
  • For Entrepreneurs
    • Search Technologies
    • Accelerate
    • Entrepreneurship & More

Tag: Atsena Therapeutics

Atsena Therapeutics Announces Dosing Complete for Adults in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-Linked Retinoschisis (Globe Newswire)

UF startup Atsena Therapeutics announced that dosing is complete in adults enrolled in Part B of the LIGHTHOUSE study, the Phase I/II/III clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).

Atsena Therapeutics Announces Alignment With FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)

UF startup Atsena Therapeutics received FDA approval to expand its Phase 1/2 LIGHTHOUSE study of ATSN-201 into a pivotal Phase 1/2/3 trial to support a BLA submission for treating X-linked retinoschisis (XLRS).

Atsena Therapeutics Announces Positive Clinical Data From Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis (XLRS)

UF startup Atsena Therapeutics announced positive clinical data results from Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).

Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis

UF startup Atsena Therapeutics announced that the U.S. FDA has granted Regenerative Medicine Advanced Therapy designation for ATSN-201 for the treatment of X-linked retinoschisis.

Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing To Further Advance Ocular Gene Therapy Programs

UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on reversing or preventing blindness, announced the successful close of an oversubscribed $150 million Series C financing round.

Atsena Therapeutics Granted U.S. FDA Fast Track Designation for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis

UF startup Atsena Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).

Atsena Therapeutics Initiates Part B of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 To Treat X-Linked Retinoschisis

UF startup Atsena Therapeutics, a clinical-stage gene therapy company specializing in genetic medicine to reverse or prevent blindness, has announced the initiation of Part B of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating the subretinal injection of ATSN-201 for treating XLRS.

Atsena Therapeutics Announces Dosing Completed in Part A of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 To Treat X-Linked Retinoschisis

UF startup Atsena Therapeutics announced dosing has been completed in Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).

How Atsena Got Its Gene Therapy To Spread Subretinally To Treat XLRS

UF researcher Sanford Boye, co-founder and adviser of UF Startup Atsena Therapeutics, shared insights into how the company developed its gene therapy to achieve subretinal spread for treating XLRS.

Atsena Therapeutics and Nippon Shinyaku Enter Exclusive License Agreement for ATSN-101

Atsena Therapeutics Inc., a UF Startup, has entered into an exclusive license agreement with Nippon Shinyaku Co., Ltd. for the commercialization of ATSN-101 in the United States, and for its development and commercialization in Japan.

Next →
Logo for UF Innovate
Facebook-f X-twitter Youtube Linkedin Instagram

Contact

Tech Licensing: (352) 392-8929
Ventures: (352) 392-8929
Pathways: (352) 392-2577
The Hub: (352) 294-0885


747 SW 2nd Avenue
Gainesville, FL 32601



Sid Martin Biotech:
(386) 462-0880
12085 Research Drive
Alachua, FL 32615

Marketing Requests

  • Our Brand
  • Marketing Requests:
UF Innovate Staff
  • Marketing Requests: Accelerate Clients
  • Tech Tuesday
Interest Form
  • Our Brand
  • Marketing Requests:
UF Innovate Staff
  • Marketing Requests: Accelerate Clients
  • Tech Tuesday
Interest Form

Resources

  • Events
  • News
  • UF Research
  • Events
  • News
  • UF Research

Website

  • Privacy Policy
  • Accessibility
  • UF Public Records
  • UF Regulations
  • Sitemap
  • Privacy Policy
  • Accessibility
  • UF Public Records
  • UF Regulations
  • Sitemap
  • © 2025 University of Florida
  • Accessibility
  • Privacy Policy
  • © 2025 University of Florida
  • Accessibility
  • Privacy Policy
X